Raia Drogasil company profile
Company profile
Raia Drogasil has 77,428 employees and is headquartered in São Paulo, Brazil.
Raia Drogasil's sales are made in Brazil, where the company runs a retail network selling pharmaceutical and health goods. Its range covers medicines of several kinds, perfumery, personal care and beauty lines, cosmetics, dermocosmetics and specialty drugs. Customers buy through physical stores, while telesales and call centers serve as additional routes to market. The company's activity is concentrated on the domestic market, and the group traces its origins back to 1905.
In the fiscal year ended 31 December 2025, revenue reached BRL 44.3 billion, 13.8% higher than a year earlier, and net income totaled BRL 1.3 billion. The workforce numbered 77,428 employees at that date. The headquarters are in São Paulo, where the company's administration is based, and the business has operated under the Raia Drogasil name in its home market for many decades.
Company facts
- Sector
- Consumer
- Industry
- Pharmaceutical Retailers
- Country
- Brazil
- Headquarters
- Av. Corifeu de Azevedo Marques, 3097, 05339-900, São Paulo
- Employees
- 77,428
- Chief executive
- Renato Raduan
- Founded
- 1905
- Fiscal year
- January - December
- Listing
- RADL3 · B3
- Indices
- Ibovespa
- Currency
- BRL
- ISIN
- BRRADLACNOR0
- Website
- rdsaude.com.br
Raia Drogasil and its competitors
The most similar companies by business and size
| Company | Country | Market cap | Employees | Operating margin | P/E (trailing 12 months) |
|---|---|---|---|---|---|
| Raia DrogasilRADL3 | Brazil | $4.04B | 77,428 | 6.1% | 17.6 |
| Alibaba Health Information Tech0241 | Hong Kong SAR China | $5.4B | 1,394 | 5.3% | 20.1 |
| Redcare PharmacyRDC | Germany | $1.47B | 2,163 | 0.3% | — |
| JD Health International6618 | Hong Kong SAR China | $13.26B | 6,018 | 6.1% | 15.0 |
| InRetail PerúINRETC1 | Peru | $3.97B | 50,571 | 9.2% | 13.5 |
| CencosudCENCOSUD | Chile | $4.56B | 116,554 | 4.9% | 23.8 |
Competitors: same or related industry, same region first, then the closest market capitalization. Market cap converted into US dollars at the latest exchange rates; P/E over the last 12 months, not shown when negative.
